Home › Stocks › COAG › Changes

Who bought & sold COAG (Q2 2026)

Funds holding (Q2 2026)59
New positions59
Added0
Reduced0
Exited0

As of Q2 2026, 59 institutional funds reported holding COAG (HEMAB THERAPEUTICS HLDGS INC): 59 opened new positions, 0 added, 0 trimmed and 0 exited entirely. 13F filings are quarter-end snapshots of positioning, not intra-quarter trades.

New positions (20 of 59)

Fund Shares Value Weight
RA CAPITAL MANAGEMENT, L.P. New 7.81M $286.81M 2.5
Novo Holdings A/S New 4.18M $153.55M 8.9
Fidelity Management & Research (FMR) New 3.70M $135.82M 0.0
Capital International Investors New 3.60M $132.37M 0.0
Deep Track Capital, LP New 3.60M $132.30M 2.0
Siren, L.L.C. New 2.09M $76.65M 1.6
Avoro Capital Advisors LLC New 1.93M $70.71M 0.6
Bain Capital Life Sciences Investors, LLC New 1.65M $60.60M 3.6
JPMorgan Chase & Co New 1.15M $42.33M 0.0
VANGUARD CAPITAL MANAGEMENT LLC New 780.76K $28.68M 0.0
PRICE T ROWE ASSOCIATES INC /MD/ New 746.04K $27.40M 0.0
DRIEHAUS CAPITAL MANAGEMENT LLC New 715.79K $26.29M 0.2
Rock Springs Capital Management LP New 575.43K $21.14M 1.0
Bellevue Group AG New 550.00K $20.20M 0.4
Citadel Advisors New 523.45K $19.23M 0.0
BlackRock Inc New 283.83K $10.43M —
DEERFIELD MANAGEMENT COMPANY, L.P. New 275.00K $10.10M 0.1
ExodusPoint Capital Management, LP New 218.29K $8.02M 0.1
GEODE CAPITAL MANAGEMENT, LLC New 211.80K $7.78M —
Geode Capital Management New 211.80K $7.78M —

Added to positions (0)

No adds this quarter.

Reduced positions (0)

No trims this quarter.

Exited positions (0)

No exits this quarter.